IP is actively recruiting oncology/hematology healthcare experts to serve on our professional bureau of paid advisors.
Strategic Advisory Bureau
Innovation Partners is actively recruiting advisors to support insights across Medical Affairs & Education, Market & Payer Access, and Quantitative and Qualitative Market Research on behalf of our clients who are seeking access for their innovative therapies.
Take our five-minute survey to see if you qualify to join our panel of strategic advisors.
Be at the forefront of healthcare trends, innovations and shaping treatment options.
Utilize your deep expertise to make a meaningful impact to the way care is delivered.
Privacy offered if desired. Double-blinded, no conflict of interest.
Be rewarded for your expertise, and no obligation required! You choose the engagements and format that are convenient for you.
Provide solutions that directly impact patient care and access to treatments.
IP’s relationships are global and span the entire spectrum of healthcare delivery. We are seeking to build upon our growing network of experts.
Testimonials from Strategic Advisors
IP is a very professional, well prepared and knowledgeable company to work with. They are on the cutting edge of drug information and technology.
Director of Pharmacy
Integrated Deliver Network
[IP] brings the best minds together on issues of the day. Very open to collaboration.
Tim Paine, VP Pharma Strategy and Relations
Fairview Pharmacy Services
[Innovation Partners] is very engaged with their partners. [There is a] lot of follow up on specific issues.
Jack Erter, MD
Tennessee Oncology, PLLC.
Very good relationships [sets IP apart]. [They engage on] good topics and the interviewers stay on time.
Dan Kus, VP
Pharmacy Services, Henry Ford Health System
IP displays the most current knowledge and insights in today’s specialty pharmacy marketplace. They have been invaluable partners to work with and are always focused on the customer, honest feedback, and integrity.
Clinical Operations Manager
IP has expertise across the hematology & oncology spectrum.
VP, Specialty Contracting & Management
Henry Ford Health System
For Our Team!
Take our five-minute survey to
see if you qualify to join our panel of strategic advisors.
A European-based pharmaceutical company with several products in the US market was under pressure to interpret and respond to rapidly changing US healthcare policies which could potentially impact access for their portfolio of oncology products.
A biopharmaceutical company was in the midst of bringing its first product to market with breakthrough therapy designation. The PDUFA date was fast approaching, and their small team needed guidance to steer them through the complicated access and reimbursement landscape.
A mid-sized pharmaceutical company was looking to enter the European market through a compassionate use/early access pathway but lacked an understanding of the requirements specific to each country that would lead to broad access and reimbursement for their product across Europe.